That's a gross oversimplification of a very common business practice used in both corporate applications and especially in health.Proper guidance is invaluable. Especially when dealing with FDA like entities.
Ann: Proposed issue of securities - EIQ, page-6
Add EIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.5¢ |
Change
0.010(6.06%) |
Mkt cap ! $94.08M | |||
| Open | High | Low | Value | Volume |
| 17.0¢ | 17.5¢ | 16.5¢ | $74.86K | 435.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 300000 | 17.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.5¢ | 233981 | 3 |
View Market Depth
| Last trade - 16.10pm 04/07/2024 (20 minute delay) ? |
| EIQ (ASX) Chart |